XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Cumulative Effect Period of Adoption Adjustment
Cumulative Effect Period of Adoption Adjustment
Accumulated deficit
Beginning Balance, Stockholders' equity at Dec. 31, 2021 $ 131,907 $ 27 $ 223,336 $ (4,457) $ (86,999) $ (401) $ (401)
Beginning Balances, Stockholders' equity (in shares) at Dec. 31, 2021   27,505          
Issuance of common stock in public offering, net of issuance costs 30,774 $ 3 30,771        
Issuance of common stock in public offering, net of issuance costs (in shares)   2,884          
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes 1,975   1,975        
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes (in shares)   579          
Stock-based compensation 15,802   15,802        
Net loss (41,270)       (41,270)    
Subsidiary dissolution (68)     (68)      
Other comprehensive loss (137)     (137)      
Ending Balances, Stockholders' equity at Dec. 31, 2022 $ 138,582 $ 30 271,884 (4,662) (128,670)    
Ending Balances, Stockholders' equity (in shares) at Dec. 31, 2022 30,968 30,968          
Accounting Standards Update [Extensible Enumeration] Cumulative effect of ASC 326 adoption            
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes $ (101) $ 1 (102)        
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes (in shares)   1,154          
Issuance of warrants 7,238   7,238        
Stock-based compensation 15,843   15,843        
Net loss (135,218)       (135,218)    
Other comprehensive loss (3,785)     (3,785)      
Ending Balances, Stockholders' equity at Dec. 31, 2023 $ 22,559 $ 31 $ 294,863 $ (8,447) $ (263,888)    
Ending Balances, Stockholders' equity (in shares) at Dec. 31, 2023 32,122 32,122